Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
White Tale Holdings
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
White Tale Holdings is an investment vehicle and activist investor group formed by Corvex Management and 40 North. The firm gained significant prominence in the life sciences and specialty chemicals sector through its substantial stake in Clariant, a global leader in specialty chemicals with major operations in healthcare packaging and pharmaceutical ingredients. White Tale's primary business involves strategic investment and corporate governance activism to drive shareholder value. While not a traditional biotechnology developer, its influence on major healthcare-related chemical suppliers makes it a notable entity in the broader life sciences ecosystem.
- Industry
- Investors
Beyond the preview
Go deeper on White Tale Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on White Tale Holdings.